| Southern Research Institute Patent applications |
| Patent application number | Title | Published |
|---|
| 20120136142 | Vaccine Compositions For Marburg Virus - Methods and immunogenic compositions for generating an immune response against Marburg virus are provided. The immunogenic composition includes antigens obtained from a Marburg viral strain in combination with an oleanolic acid triterpene adjuvant. | 05-31-2012 |
| 20110301165 | METHOD FOR TREATING AND PREVENTING ARTHRITIS - Compounds represented by the formula 1: | 12-08-2011 |
| 20110218170 | USE OF 2'-DEOXY-4'-THIOCYTIDINE AND ITS ANALOGUES AS DNA HYPOMETHYLATING ANTICANCER AGENTS - Compounds represented by the formulae: | 09-08-2011 |
| 20110212073 | PURINE NUCLEOSIDE PHOSPHORYLASE AS ENZYMATIC ACTIVATOR OF NUCLEOSIDE PRODRUGS - A process for inhibiting a mammalian cancerous cell or virally infected cell includes providing a | 09-01-2011 |
| 20110191036 | DIRECT CONTACT FORCE MEASUREMENT SYSTEM - A system for measuring forces from a rotating object is presented. In one aspect, the measurement system has a plurality of strain sensors that are configured to attach to the sidewall of a tire of a vehicle and measure the strain on the sidewall. The system can also have a data processor to relate the strain on the sidewall to the normal force exerted on the driving surface from the tire. | 08-04-2011 |
| 20100216797 | PREPARATION OF THIOARABINOFURANOSYL COMPOUNDS AND USE THEREOF - Patients suffering from cancer are treated by being administered a compound represented by the following formula: | 08-26-2010 |
| 20100204338 | ANTI-ANGIOGENIC AGENTS AND METHODS OF USE - The present disclosure relates generally to treating or preventing diseases associated with angiogenesis by administering to a patient certain compounds found to inhibit or substantially reduce angiogenesis. Compounds employed according to the present disclosure exhibit good anti-angiogenic activity as well as demonstrate a prophylactic effect for preventing and substantially reducing angiogenesis. Examples of such compounds include Ritanserin, Amiodarone, Terfenadinc, Perphenazine, Bithionol, and Clomipramine. | 08-12-2010 |
| 20100129317 | AZOLE NUCLEOSIDES AND USE AS INHIBITORS OF RNA AND DNA VIRAL POLYMERASES - Azole nucleosides represented by the formulae (I) and (II); wherein A=C or N B═C or N X═H; C | 05-27-2010 |
| 20100120745 | ANTI-ANGIOGENIC AGENTS AND METHODS OF USE - The present disclosure relates generally to treating or preventing diseases associated with angiogenesis by administering to a patient certain compounds found to inhibit or substantially reduce angiogenesis. Compounds employed according to the present disclosure exhibit good anti-angiogenic activity as well as demonstrate a prophylactic effect for preventing and substantially reducing angiogenesis. Examples of such compounds include Ritanserin, Amiodarone, Terfenadine, Perphenazine, Bithionol, and Clomipramine. | 05-13-2010 |
| 20100120679 | Targeting NBS1-ATM Interaction To Sensitize Cancer Cells To Radiotherapy And Chemotherapy - Provided herein are compositions and methods for use in sensitizing cancer cells to radiation and chemotherapy. | 05-13-2010 |
| 20090239892 | PYRIDOMORPHINANS, PYRIDAZINOMORPHINANS AND USE THEREOF - Compounds represented by the formula: | 09-24-2009 |
| 20080312329 | Nonpeptide Inhibitors of Matrix Metalloproteinases - Disclosed are selective inhibitors of matrix metalloproteinases represented by the following formula (I). | 12-18-2008 |
| 20080234275 | METHOD FOR TREATING AND PREVENTING ARTHRITIS - Compounds represented by the formula 1: | 09-25-2008 |
